This brand name is authorized in Brazil
The drug NOVANLO contains one active pharmaceutical ingredient (API):
|
1
Levamlodipine
UNII 885H5YC40L - LEVAMLODIPINE BESYLATE
|
|
Levamlodipine is the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker. It is used for the treatment of hypertension in adults and pediatric patients, to lower blood pressure. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C08CA17 | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 504112070049602, 504112070049702, 504112070049802, 504112070050102, 504112070050202, 504112070050302 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
